During the past decade, Klinikum Augsburg; Frauenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Augsburg; Frauenklinik" are "Metastatic Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Augsburg; Frauenklinik" in a lesser frequency.

Most popular intervention types in "Klinikum Augsburg; Frauenklinik" are "Drug" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "FDC of Pertuzumab and Trastuzumab SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Augsburg; Frauenklinik" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Augsburg; Frauenklinik". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Augsburg; Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Augsburg; Frauenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".